Phio Pharmaceuticals Corp (PHIO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Gerrit Dispersyn
Employees:
9
257 SIMARANO DRIVE, SUITE 101, MARLBOROUGH, MA 01752
(508) 767-3861

Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 9.583 Million Shares Outstanding13.535 Million Avg 30-day Volume 921.096 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.0177 EBITDA-8.722 Million
Price to Book Value0.948 Operating Margin0.0 Enterprise Value-1.723 Million
Current Ratio6.905 EPS Growth0.901 Quick Ratio6.486
1 Yr BETA 1.3642 52-week High/Low 2.47 / 0.62 Profit Margin0.0
Operating Cash Flow Growth-1.8161 Altman Z-Score-7.3515 Free Cash Flow to Firm -6.345 Million
View SEC Filings from PHIO instead.

View recent insider trading info

Funds Holding PHIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PHIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRADFORD PATRICIA A

  • Director
0 2022-04-27 1

KONTULIS CAITLIN SECRETARY & VP FINANCE & ADMIN

  • Officer
103,815 2022-03-01 2

DISPERSYN GERRIT PRESIDENT & CEO

  • Officer
  • Director
212,327 2022-03-01 3

CAUWENBERGH GEERT

  • Director
32,822 2022-02-15 1

BITTERMAN ROBERT J

  • Director
25,826 2022-02-15 1

LOCKSHIN CURTIS

  • Director
20,366 2022-02-15 1

DORMAN H. PAUL

  • Director
20,370 2022-02-15 1

FREEMAN JONATHAN E

  • Director
20,364 2022-02-15 1

FERRARA ROBERT L

  • Director
23,000 2022-02-15 1

BARRETT JOHN A CHIEF DEVELOPMENT OFFICER

  • Officer
222,991 2019-04-22 0

BROWNLIE KEITH L

  • Director
20,000 2019-02-13 0

ELISEEV ALEXEY CHIEF BUSINESS OFFICER

  • Officer
950,312 2017-09-05 0

PAVCO PAMELA CHIEF DEVELOPMENT OFFICER

  • Officer
0 2017-02-01 0

ADVANCED RNA TECHNOLOGIES, LLC

  • NO LONGER 10% OWNER
No longer subject to file 2014-07-31 0

GALENA BIOPHARMA, INC.

  • 10% Owner
No longer subject to file 2013-04-30 0

OPKO HEALTH, INC.

  • 10% Owner
67,241,380 2013-03-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 16:45:03 UTC -42.5499 43.3699 700000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 16:15:03 UTC -42.5499 43.3699 700000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 15:45:03 UTC -42.5499 43.3699 700000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 15:15:03 UTC -42.5499 43.3699 700000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 14:45:03 UTC -42.4236 43.2436 650000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 14:15:03 UTC -42.4236 43.2436 650000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 13:45:04 UTC -42.4236 43.2436 650000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 13:15:03 UTC -42.4236 43.2436 850000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-16 12:45:04 UTC -42.4236 43.2436 850000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 22:15:03 UTC -42.4236 43.2436 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 21:45:03 UTC -42.4236 43.2436 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 21:15:03 UTC -42.4236 43.2436 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 20:45:03 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 20:15:03 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 19:45:04 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 19:15:03 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 18:45:03 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 18:15:03 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 17:45:03 UTC -38.4063 39.2263 350000
PHIO PHARMACEUTICALS CORP PHIO 2022-05-13 17:15:03 UTC -38.4063 39.2263 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments